Published November 30, 2023 | Version CC-BY-NC-ND 4.0
Journal Open

Scientific Evaluation of A Unani Pharmacopoeia-Based Formulation on BPH in Animal Model

Creators

  • 1. Research Scholar, Department of Ilmul Advia, Ajmal Khan Tibbia College, Faculty of Unani Medicine, AMU, Aligarh (UP), India.

Contributors

  • 1. Research Scholar, Department of Ilmul Advia, Ajmal Khan Tibbia College, Faculty of Unani Medicine, AMU, Aligarh (UP), India.
  • 2. Assistant Professor, Department of Ilmul Advia, Ajmal Khan Tibbia College, Faculty of UnaniMedicine, AMU, Aligarh (UP), India.
  • 3. Assistant professor, Department of Pathology, Jawahar Lal Nehru Medical College, AMU, Aligarh (UP), India.

Description

Abstract: BPH (Benign prostatic hyperplasia) is a common problem of the prostate gland that affects elderly men with age and major cause of lower urinary tract symptoms (LUTS) like urgency of urination, frequency of micturition, dysuria, nocturia, dribbling, and burning of urine. If left untreated, the condition can lead to severe urinary retention, recurrent UTI, and, in severe cases, renal failure, etc. Alpha-blockers and 5-alpha reductase inhibitors (5-ARIs) are two main classes of drugs that are used in conventional therapy to treat BPH. These phytochemical therapies are extremely effective, but standard control methods have unfavorable side effects too. Conversely, evidence, though limited, has shown that alternative medicines are safer and have the potential to improve LUTS and quality of life, in addition to improving sexual dysfunction in patients with BPH. The purpose of the study is to assess the efficacy of 50% hydroalcoholic UPBF extract on BPH in TP-induced rats, and the effects of the drug were compared between the treated and untreated groups. The experimental design for anti-BPH activity was carried out following the Bhavin model. 48 Wistar rats were divided into 6 groups, with 8 rats in each group. Group 1, plane control (untreated rats), group 2, negative control (treated with TP 5 mg/kg), group 3, negative control (treated with TP+ finasteride 1 mg/kg), and groups 4,5 and 6 served as tests controls (A, B, and C) treated with TP+ UPBF extract 100 mg/kg, 150 mg/kg, and 200 mg/kg as low, medium, and high doses, respectively. BPH was induced in rats by administration of testosterone propionate (TP) in arachis oil, and treatment was done orally with a standard drug (finasteride) and a test drug (UPBF) once a day for 28 consecutive days. Before and after initiating the study, each rat was weighed and documented, and after 28 days, the collection of blood samples and the prostate gland was done under light anesthesia. The parameters of the study were accessed, like prostate weight, prostate-to-body weight ratio, histopathological investigation of the prostate, percentage of inhibition, percentage of recovery, and determination of ST and STP levels. Data from the results were expressed as the mean ± standard error of the mean (SEM). Evaluation between group results was carried out with the one-way ANOVA test followed by Tukey's test, and the significant value of p was <0.05. Both histopathological and biochemical parameter results showed significant improvements in rats treated with finasteride and UPBF extract at a dose of 200 mg/kg (p<0.001). In addition, ST and STP levels showed a significant reduction in comparison with the BPH group. It can be concluded from the findings of the results in both biochemicals and histopathological parameters that the test drug (UPBF) possesses significant effects against the TP-induced BPH in rats. The findings suggested that the test drug can be used independently in the management of BPH as well as for lower urinary tract symptoms.

Files

A1032114123.pdf

Files (765.0 kB)

Name Size Download all
md5:5029bc74beaaf6213f30b8dd0bc79383
765.0 kB Preview Download

Additional details

Identifiers

DOI
10.54105/ijpmh.A1032.114123
ISSN
2582-7588

Dates

Accepted
2023-11-15
Manuscript received on 10 September 2023 | Revised Manuscript received on 13 October 2023 | Manuscript Accepted on 15 November 2023 | Manuscript published on 30 November 2023

References

  • Roehrborn, C. G. Benign prostatic hyperplasia: An overview. Rev Urology, vol. 7, Sup. 9, S3-S14. (2007). https://doi.org/10.1016/S0084-4071(08)70077-0
  • Iscaife, A., Anjos, A. D., Neto, C. B., Nahas, C. et al. The role of bladder diverticula in the prevalence of acute urinary retention in patients with BPH who are candidates for surgery. Int Braz J. Urology Jul-Aug; vol. 44, Suppl 4, pp. 765-70, (2018). https://doi.org/10.1590/s1677-5538.ibju.2017.0605
  • Barnard, R. J., Aronson, W. J. Benign Prostatic Hyperplasia: Does Lifestyle Play a Role? The Physician and Sports Medicine, vol. 37, Sup. 4, pp. 141–46, (2009). https://doi.org/10.3810/psm.2009.12.1752
  • DiBello, J. R., Ioannou, C., Rees, J., et al. Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study. BJU International, vol. 117, no. 5, pp. 801–8, (2016). https://doi.org/10.1111/bju.13334
  • Vickman, R. E., Franco, O. E. et al. The role of the androgen receptor in prostate development and benign prostatic hyperplasia. A review. Asian J. Urology. Jul; vol. 7, no. 3, pp. 191-202, (2020). https://doi.org/10.1016/j.ajur.2019.10.003
  • Krieg, M., Nass, R., Tunn, S. Effect of aging on endogenous levels of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in the epithelium and stroma of normal and hyperplastic human prostate. J Clin Endocrinology Metab. Aug; vol. 77, no. 2, pp. 375-81, (1993). https://doi.org/10.1210/jcem.77.2.7688377
  • Le, V., He, Y., Aldahl, J., Hooker, E., Yu, EJ., Olson, A., et al. Loss of androgen signaling in mesenchymal sonic hedgehog-responsive cells diminishes prostate development, growth, and regeneration. PLoS Genet. Jan 13; vol. 16, no. 1, pp. 1-22, (2020). https://doi.org/10.1371/journal.pgen.1008588
  • Kato, M., Sasaki, T., Inoue, T. Current experimental human tissue-derived models for prostate cancer research. Int. J. Urol. Feb; vol. 28, no. 2, pp. 150-62, (2021). https://doi.org/10.1111/iju.14441
  • Ibn Zuhr, A. M. Amraz Kuliya Wa Mathana. (Edit. Ahmad, B.) Kitab-Al-Taiseer-Fil-Madawat-Al Tadbır. New Delhi: Central Council for Research in Unani Medicine, pp. 164-166, (1986).
  • Kantori, G. H. Amraz-e-Juz'ia in Kitab at-Qanun fit-Tibb (Edit. & transl. Sina, S. R.). New Delhi: Ejaz Publishing House, New Delhi, pp. 1018-30, (2010).
  • Jurjani, A. H. Amraz Mathana in Zakhıra Khwarzam Shahi (edit. & Transl. Khan, H. H.) New Delhi: Idara Kitabul Shifa, pp. 525-31, (2010).
  • Razi, A. B. Z. Amraz Minal Qarnel al- Qadam. In Kitabul-Hawı-fil-Tibb (Edit. and transl. CCRUM) New Delhi: Central Council for Research in Unani Medicine, pp. 148-78, (2002)
  • Lee, C. L., Kuo, H. C. Pathophysiology of benign prostate enlargement and lower urinary tract symptoms: current concepts. Ci Ji Yi Xue Za Zhi. Apr-Jun, vol. 29, no. 2, pp 79-83, (2017). https://doi.org/10.4103/tcmj.tcmj_20_17
  • Khan, M. A. Amraz Mathana in Aks-ır-i-Azam (Edit. Kabiruddin, M.) New Delhi: Ejaz Publishing House, pp. 728-34, (2010).
  • Mohammad, M., Zarshenas, M. M., Moein, M., Samani, S. M., Petramfar, P. An Overview of Ajwain (Trachyspermum ammi) Pharmacological Effects. Modern and Traditional Journal of Natural Remedies, vol. 14, no. 1, pp. 99–105, (2014).
  • Vishwakarma, V. K., Gupta, J. K., Upadhyay, P. K. PHARMACOLOGICAL IMPORTANCE OF CUCUMIS MELO L: AN OVERVIEW. Asian Journal of Pharmaceutical and Clinical Research. Mar, vol. 10, no. 3, pp. 8–12, (2017). https://doi.org/10.22159/ajpcr.2017.v10i3.13849
  • Pethakar, S. R., Hurkadale, P.J., Hiremath, R.D. Evaluation of Anti-urolithiasis Potentials of Hydro-Alcoholic Extract of Cucumis sativus L. Indian Journal of Pharmaceutical Education and Research, vol. 51, no. 10-12, pp. 607-14, (2017). https://doi.org/10.5530/ijper.51.4s.89
  • Hu, C., Kitts, D. D. Dandelion (Taraxacum officinale) flower extract suppresses both reactive oxygen species and nitric oxide and prevents lipid oxidation in vitro. Phytomedicine. Aug, vol. 12, no. 8, pp. 588-97, (2005). https://doi.org/10.1016/j.phymed.2003.12.012
  • Ahmad, K., Najar, F. A., Faisal, M., Ansari, T. A. Efficacy of Banadiq-ul-Buzoor in Improving the Quality of Life of Patients of Benign Prostatic Hypertrophy: An Open Labelled Observational Clinical Study. Research & Reviews: Journal of Surgery. vol. 6, no. 3, pp. 7–11, (2017).
  • Choi, E. M., Hwang, J. K. Anti-inflammatory, analgesic and antioxidant activities of the fruit of Foeniculum vulgare. Fitoterapia. Sep; vol. 75, no. 6, pp. 557-65, (2004). https://doi.org/10.1016/j.fitote.2004.05.005
  • Khan, M., Haque, M. S., Chowdhury, M. S. I. Medicinal use of the unique plant Tinospora cordifolia: evidence from the traditional medicine and recent research. Asian Journal of Medical and Biological Research, vol. 2, no. 4, pp.508–512, (2017). https://doi.org/10.3329/ajmbr.v2i4.30989
  • Sharma, P., Parmar, J., Verma, P., Sharma, P., Goyal, P. K. Anti-tumor activity of Phyllanthus niruri (a medicinal plant) on chemical-induced skin carcinogenesis in mice. Asian Pac J Cancer Prev, vol. 10, no. 6, pp. 1089-94, (2009).
  • Mattioli, R., Francioso, A., Mosca, L., and Silva, P. Anthocyanins: A comprehensive review of their chemical properties and health effects on cardiovascular and neurodegenerative diseases. Molecules, vol. 25, no.17, Aug 21, (2020) https://doi.org/10.3390/molecules25173809
  • Cavin, C., Delannoy, M., Touche, A., Courtois, D., and Schilter, B. Inhibition of the expression and activity of cyclooxygenase2 by chicory extract: Biochem Biophys Res Commun, vol. 327, no. 3, pp. 742-749, (2005). https://doi.org/10.1016/j.bbrc.2004.12.061
  • Nadkarni, K. M. Indian Materia Medica. Popular Prakashan, Mumbai, vol. I no. 3, pp. 1229–1232, (1984).
  • Jabbar, A., Nazir, A., Ansari, N.I., Javad, F., Mahmood, K. et al. Effects of Tribulus terrestris on urine output and electrolytes in rabbits. Professional Med J, vol. 19, no. 6, pp. 843–847, (2012). https://doi.org/10.29309/TPMJ/2012.19.06.2464
  • Karnick, C. R. Pharmacology of Ayurvedic Medicinal Plants. Sri Satguru Publications, Delhi, December 31, pp. 17, (1996).
  • Duke, J. A. Handbook of Medicinal Herbs. CRC Press, New York, Edition 2, pp. 113-114, (2002). https://doi.org/10.1201/9781420040463
  • Huang, M. T., Badmaev, V., Ding, Y., Liu, Y., Xie, JG., Ho, CT. et al. Anti-tumor and anti-carcinogenic activities of triterpenoid, beta-boswellic acid. Biofactors, vol. 13, no. 1-4, pp. 225-30, (2000). https://doi.org/10.1002/biof.5520130135
  • Siddiqui, M. Z. Boswellia serrata, a potential anti-inflammatory agent: an overview. Indian J Pharm Sci. (2011) May, vol. 73, no. 3, pp. 255-61, (2011).
  • Garg, S. C., Siddiqui, N. Antifungal activity of some essential oil isolates. Pharmazie, Jun; vol. 47, no. 6, pp. 467-8, (1992).
  • Sikdar, M., Dutta, U. Traditional phytotherapy among the Nath people of Assam. Ethno-Med, vol. 2, pp. 39-45, (2008). https://doi.org/10.1080/09735070.2008.11886313
  • Lai, Y. J., Tai, C. J., Wang, C. W., Choong, C. Y., Lee, B. H. Anti-Cancer Activity of Solanum nigrum (AESN) through Suppression of Mitochondrial Function and Epithelial-Mesenchymal Transition (EMT) in Breast Cancer Cells. Molecules. Apr; vol. 21, no. 5, pp. 553, (2016). https://doi.org/10.3390/molecules21050553
  • Gabrani, R., Jain, R., Sharma, A., Sarethy, I. P., Dang, S., Gupta, S. Antiproliferative Effect of Solanum nigrum on Human Leukemic Cell Lines. Indian J. Pharm Sci. Sep; vol. 74, no. 5, pp. 451-3, (2012). https://doi.org/10.4103/0250-474X.108421
  • Javed, T., Ashfaq, U. A., Riaz, S., Rehman, S., Riazuddin, S. In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus. Virol J. Jan, vol. 8, no. 26, (2011). PMID: 21247464 https://doi.org/10.1186/1743-422X-8-26
  • Hattori, M., Huang, X. L., Che, Q. M., Kawata, Y. et al. 6-hydroxy kaempferol and its glycosides from Carthamus tinctorius petals. Phytochemistry, vol. 31, pp. 4001-4004, (1992). https://doi.org/10.1016/S0031-9422(00)97572-1
  • Chang, H. T., Han, H. X., and Tu, P. F. Chemical constituents and pharmacological effects of safflower". Xiandai Yaowu Yu Linchuang, vol. 14, pp. 201-203, (1999).
  • Tien, Y.C., Lin, J. Y., Lai, C. H., Kuo, C. H. et al. Carthamus tinctorius L. prevents LPS-induced TNFalpha signaling activation and cell apoptosis through JNK1/2-NFkappaB pathway inhibition in H9c2 cardiomyoblast cells. J Ethnopharmacology. (2010) Aug 9; vol. 130, no. 3, pp. 505–13, (2010). https://doi.org/10.1016/j.jep.2010.05.038
  • Qazi, N., Khan, R. A., Rizwani, G. H., Feroz, Z. Effect of Carthamus tinctorius (Safflower) on fasting blood glucose and insulin levels in alloxan-induced diabetic rabbits. Pak J Pharm Sci. Mar; vol. 27, no. 2, pp. 377-80, (2014).
  • Arpornsuwan, T., Petvises, S., Thim-am, A., Boondech, A., and Roytrakul, S. Effects of Carthamus tinctorius L. solvent extracts on the anti-proliferation of human colon cancer (SW 620 cell line) via apoptosis and the growth promotion of lymphocytes. Songklanakarin J Sci Technol, pp. 45–51, (2012).
  • Shin, I. S., Lee, M. Y., Ha, H. K. et al. Inhibitory effect of Yukmijihwang-tang, a traditional herbal formula against testosterone-induced benign prostatic hyperplasia in rats. BMC Complement Altern Med. Vol. 12, no. 48, (2012). https://doi.org/10.1186/1472-6882-12-48
  • Keskar, M., & Maktedar, Dr. D. (2019). Enhancing Classifier Accuracy in Ayurvedic Medicinal Plants using WO-DNN. In International Journal of Engineering and Advanced Technology (Vol. 9, Issue 1, pp. 6705–6714). https://doi.org/10.35940/ijeat.a2001.109119
  • Medicinal Plants Segmentation using Thresholding and Edge based Techniques. (2019). In International Journal of Innovative Technology and Exploring Engineering (Vol. 8, Issue 6S4, pp. 71–76). https://doi.org/10.35940/ijitee.f1014.0486s419